(Q68287044)

English

Inherent β-Cell Dysfunction Induced by Transgenic Expression of Allogeneic Major Histocompatibility Complex Class I Antigen in Islet Cells

scientific article published on 01 January 1991

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Inherent beta-cell dysfunction induced by transgenic expression of allogeneic major histocompatibility complex class I antigen in islet cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Inherent β-Cell Dysfunction Induced by Transgenic Expression of Allogeneic Major Histocompatibility Complex Class I Antigen in Islet Cells (English)

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

author name string

T. E. Mandel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

J. Allison

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

I. L. Campbell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

M. Koulmanda

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

L. Malcolm

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

A. Cutri

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

J. F. Miller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669846

25 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1669846

25 October 2022

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/08916939108997123

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

47-53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells

1

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma

2

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells

3

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction

6

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies

7

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

9

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

11

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Calmodulin-induced early-onset diabetes in transgenic mice

12

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Diabetes induced in male transgenic mice by expression of human H-ras oncoprotein in pancreatic beta cells

13

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus

14

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Cyclosporin prevents diabetes in BB Wistar rats

15

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat

16

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

17

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Transfusions enriched for W3/25+ helper/inducer T lymphocytes prevent spontaneous diabetes in the BB/W rat

18

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Preventive effects of cyclosporin on diabetes in NOD mice

19

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

20

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide

21

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes

22

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Partial preservation of pancreatic beta-cell function in children with diabetes

23

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

24

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

25

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Tolerance of class I histocompatibility antigens expressed extrathymically

27

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Organ culture of fetal mouse and fetal human pancreatic islets for allografting

30

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Organ culture of fetal mouse pancreas. The effect of culture conditions on insulin and glucagon secretion

32

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Effect of ischemia and temperature on fetal mouse pancreas. Insulin production in vitro, and function after isotransplantation

33

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Effect of culture conditions on fetal mouse pancreas in vitro and after transplantation in syngeneic and allogeneic recipients

34

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release

35

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Intolerable secretion in tolerant transgenic mice

36

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus

37

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Association of beta-cell-specific expression of endogenous retrovirus with development of insulitis and diabetes in NOD mouse

40

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice.

41

1 reference

10.3109/08916939108997123

https://api.crossref.org/works/10.3109/08916939108997123

25 October 2022

Identifiers

10.3109/08916939108997123

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669846%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68287044&oldid=1757505519"